This article reviews the current literature related to the treatment of COPD exacerbations and examines whether these data support current treatment guidelines.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Regular use of spirometry for COPD progression tracking is important for COPD treatment ... Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research ...

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...